Drawing for NEUSERINE

USPTO serial 88031647

NEUSERINE

Reviewed by CopyMark Law Group

Reg. 6811004Status 700Registered
Filing date
Status date
Registration date
Aug 9, 2022
Examiner
RATCLIFFE, ROBERT L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NEUSERINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ROBERT W. ZELNICK

ROBERT W. ZELNICK MCDERMOTT WILL & EMERY LLPTHE MCDERMOTT BUILDING500 NORTH CAPITOL STREET, NWWASHINGTON, DC 20001-1531

Goods and services

ClassDescriptionStatusFirst use
005Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical reagents for medical or veterinary purposes, excluding reagents for use in development of skin care products or cosmetics; antibacterial substances for medical purposes, excluding antibacterial substances for use in skin care products or cosmetics; amino acid preparations for medical purposes, excluding amino acid preparations for use in skin care products or cosmetics; amino acids for medical or veterinary purposes, excluding amino acids for use in skin care products or cosmetics; amino acids for medical purposes, excluding amino acids for use in skin care products or cosmeticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 9, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 9, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 1, 2022TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jul 1, 2022OP.TOPPOSITION TERMINATED NO. 999999—
Jul 1, 2022OP.DOPPOSITION DISMISSED NO. 999999—
Feb 10, 2021OP.IOPPOSITION INSTITUTED NO. 999999—
Feb 10, 2021OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Jan 12, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 12, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 23, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 9, 2020OTHECASE RETURNED TO EXAMINATION—
Dec 9, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Dec 2, 2020ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Dec 2, 2020PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Dec 1, 2020APETASSIGNED TO PETITION STAFF—
Nov 14, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 12, 2020EX3GSOU EXTENSION 3 GRANTED—
Nov 12, 2020EXT3SOU EXTENSION 3 FILED—
Nov 12, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 1, 2020TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Jul 24, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 24, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 24, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 24, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 24, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 24, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 23, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 21, 2020EX2GSOU EXTENSION 2 GRANTED—
Apr 21, 2020EXT2SOU EXTENSION 2 FILED—
Apr 21, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 17, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 15, 2019EX1GSOU EXTENSION 1 GRANTED—
Oct 15, 2019EXT1SOU EXTENSION 1 FILED—
Oct 15, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 14, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 29, 2019CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Mar 26, 2019APETASSIGNED TO PETITION STAFF—
Mar 24, 2019ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Mar 5, 2019EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Dec 12, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 13, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 24, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 2, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2018DOCKASSIGNED TO EXAMINER—
Jul 14, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 13, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance